It further said that, a review of available safety data of more than 17 million people vaccinated in the European Union (EU) and UK with its vaccine has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia, in any defined age group, gender, batch or in any particular country.
